[go: up one dir, main page]

AU2003265432A8 - Polyionic organic acid formulations - Google Patents

Polyionic organic acid formulations

Info

Publication number
AU2003265432A8
AU2003265432A8 AU2003265432A AU2003265432A AU2003265432A8 AU 2003265432 A8 AU2003265432 A8 AU 2003265432A8 AU 2003265432 A AU2003265432 A AU 2003265432A AU 2003265432 A AU2003265432 A AU 2003265432A AU 2003265432 A8 AU2003265432 A8 AU 2003265432A8
Authority
AU
Australia
Prior art keywords
organic acid
acid formulations
polyionic organic
polyionic
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003265432A
Other versions
AU2003265432A1 (en
Inventor
Sean Tucker
Michael J Bennett
Hsien Tseng
Yen-Ju Chen
Edmund J Niedzinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genteric Inc
Original Assignee
Genteric Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genteric Inc filed Critical Genteric Inc
Publication of AU2003265432A8 publication Critical patent/AU2003265432A8/en
Publication of AU2003265432A1 publication Critical patent/AU2003265432A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003265432A 2002-08-12 2003-08-12 Polyionic organic acid formulations Abandoned AU2003265432A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US40281102P 2002-08-12 2002-08-12
US60/402,811 2002-08-12
US45399903P 2003-03-11 2003-03-11
US60/453,999 2003-03-11
US47614503P 2003-06-04 2003-06-04
US60/476,145 2003-06-04
PCT/US2003/025419 WO2004015089A2 (en) 2002-08-12 2003-08-12 Polyionic organic acid formulations

Publications (2)

Publication Number Publication Date
AU2003265432A8 true AU2003265432A8 (en) 2004-02-25
AU2003265432A1 AU2003265432A1 (en) 2004-02-25

Family

ID=31721505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003265432A Abandoned AU2003265432A1 (en) 2002-08-12 2003-08-12 Polyionic organic acid formulations

Country Status (2)

Country Link
AU (1) AU2003265432A1 (en)
WO (1) WO2004015089A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888107B2 (en) 2006-07-24 2011-02-15 Nanosphere, Inc. System using self-contained processing module for detecting nucleic acids
US7625746B2 (en) 2006-07-24 2009-12-01 Nanosphere, Inc. Method of denaturing and fragmenting DNA or RNA using ultrasound
CZ301561B6 (en) * 2007-12-04 2010-04-14 Výzkumný ústav živocišné výroby, v. v. i. Pharmaceutical composition to prevent and suppress coccidia
JP7770096B2 (en) 2016-10-14 2025-11-14 ザ チルドレンズ メディカル センター コーポレーション Compositions and methods for treating diseases and disorders of the central nervous system
CA3050690A1 (en) 2017-01-17 2018-07-26 Dana-Farber Cancer Institute, Inc. Compositions and methods for diagnosing and treating peroxisomal diseases
US11548936B2 (en) 2017-01-17 2023-01-10 Children's Medical Center Corporation Compositions and methods for treating lysosomal storage diseases and disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885971A (en) * 1995-03-24 1999-03-23 The Regents Of The University Of California Gene therapy by secretory gland expression
US5932539A (en) * 1996-10-15 1999-08-03 The Board Of Trustees Of The University Of Illinois Biodegradable polymer matrix for tissue repair
US6372722B1 (en) * 2000-01-19 2002-04-16 Genteric, Inc. Method for nucleic acid transfection of cells
US20020108132A1 (en) * 2001-02-02 2002-08-08 Avigenics Inc. Production of a monoclonal antibody by a transgenic chicken

Also Published As

Publication number Publication date
WO2004015089A2 (en) 2004-02-19
WO2004015089A3 (en) 2004-07-15
AU2003265432A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
IL165349A0 (en) Microcapsule formulations
AU2003296419A1 (en) Pyrenyloxysulfonic acid fluorescent agents
IL162642A0 (en) Formulations
AU2004266485A1 (en) Phenoxiacetic acid derivatives
AU2003301516A8 (en) Antifungal formulations
SI1513514T1 (en) Hydroxymatairesinol topical formulations
GB0319874D0 (en) Novel formulation
SG123557A1 (en) Chemical amplified photoresist compositions
GB0207438D0 (en) Formulation
GB0323701D0 (en) Formulations
GB0205504D0 (en) Formulation
GB0318448D0 (en) Formulation
TWI340160B (en) Organic acid containing compositions and methods for use thereof
AU2002350942A8 (en) Imidazolidineacetic acid derivatives
GB0606187D0 (en) Acid containing oxaliplatin formulations
GB0312195D0 (en) Formulation
AU2003265432A8 (en) Polyionic organic acid formulations
GB0307765D0 (en) Tissue-adhesive formulations
GB0218194D0 (en) Solid formulations
GB0320522D0 (en) Formulation
DE50312758D1 (en) drawbar
PL364014A1 (en) Veterinary compounds
GB0303876D0 (en) Formulation
DE50306664D1 (en) cinnamic acid
GB2441445A8 (en) Acid containing oxaliplatin formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase